Using Virtual Reality to Help Kids with Kidney Disease During Dialysis
Impact of Virtual Reality on Pain, Anxiety and Depression in Pediatric Patients with ESRD on Regular Hemodialysis Through Arteriovenous Fistula.
This study is testing if using virtual reality can help kids with kidney disease feel less pain and anxiety during their dialysis treatments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 8 Years to 18 Years |
| Sex | All |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta) |
| Trial ID | NCT06675877 on ClinicalTrials.gov |
What this trial studies
This case control study aims to evaluate the effectiveness of Virtual Reality (VR) in reducing pain and anxiety during arteriovenous cannulation in pediatric patients with end-stage renal disease (ESRD) undergoing regular hemodialysis. Conducted at Tanta University Hospital, the study will involve 60 participants aged 8 to 18, divided into two groups: one receiving VR intervention and the other serving as a control. The study will last for six months, focusing on the psychological and physical impacts of VR on these young patients.
Who should consider this trial
Good fit: Ideal candidates are children and adolescents aged 8 to 18 with ESRD on regular hemodialysis who experience anxiety or depression.
Not a fit: Patients with temporary or permanent catheters for dialysis, mental illnesses, or those not experiencing anxiety or depression may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly alleviate pain and anxiety for pediatric patients undergoing hemodialysis.
How similar studies have performed: While the use of VR in medical settings is gaining traction, this specific application in pediatric hemodialysis is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pediatric patients with end stage renal disease aged from 8 to 18 years on regular hemodialysis through functioning arteriovenous fistula and are fully oriented with time, persons and place at time of data collection. All participants either cases or controls suffer from anxiety, depression or both. Exclusion Criteria: * Children with temporary or permanent catheter for dialysis. * Children with mental illness, visual and auditory defects. * Children took any pharmacological pain reliever or antipsychotic drugs. * Non anxious or depressed Children.
Where this trial is running
Tanta
- Tanta University Hospital — Tanta, Egypt (Recruiting)
Study contacts
- Principal investigator: sara Ma ElGhoul, MD — Tanta university hospital
- Study coordinator: Sara Ma ElGhoul, MD
- Email: sara.mabrouk@med.tanta.edu.eg
- Phone: 01099204120
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.